Application of danshinolic acid B in inhibition of islet amyloid polypeptide aggregation and treatment of diabetes
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HUAZHONG UNIV OF SCI & TECH
- Publication Date
- 2013-03-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicine and relates to a medicine for treating diabetes. Background technique
[0002] Diabetes is an endocrine disease caused by the body's own nutritional and metabolic disorders. Its basic biochemical characteristics are persistent high blood sugar. It has become the fifth leading cause of death in the world. disease.
[0003] Diabetes is divided into type 1 and type 2, and the number of type 2 diabetes (T2DM) accounts for more than 90% of the total number of diabetic patients. The basic feature of type 2 diabetes is: on the basis of insulin resistance, the function of β cells is damaged. The pathogenesis of type 2 diabetes has not yet been elucidated. Islet amyloid polypeptide (Islet amyloidpolypeptide, IAPP) is co-secreted by pancreatic β cells together with insulin, and consists of 37 amino acid polypeptides. Under physiological conditions, IAPP can cooperate with blood sugar regulating hormones such as i...